Analysts think ASMB stock price could increase by 303%
Apr 05, 2025, 11:25 AM
60.18%
What does ASMB do
Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
5 analysts think ASMB stock price will increase by 302.71%. The current median analyst target is $35.70 compared to a current stock price of $8.87. The lowest analysts target is $31.31 and the highest analyst target is $37.80.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.